Want to join the conversation?
$ANGO said it has agreed with Merz North America, U.S. affiliate of the global Merz Pharma Group, to serve as the exclusive distributor of Asclera (polidocanol) Injection within the vein market in the U.S. Asclera is approved for the treatment of uncomplicated spider and uncomplicated reticular (small varicose) veins.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.